{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T22:53:58Z","timestamp":1754261638777,"version":"3.41.2"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2018,8,7]]},"abstract":"<jats:sec xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">It is not clear whether the effects of lipid\u2010lowering or antihypertensive medications are influenced by adherence to healthy lifestyle factors. We assessed the effects of both drug interventions in subgroups by the number of healthy lifestyle factors in participants in the HOPE\u20103 (Heart Outcomes Prevention Evaluation) trial.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Methods and Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              In this primary prevention trial, 4 healthy lifestyle factors (nonsmoking status, physical activity, optimal body weight, and healthy diet) were recorded in 12\u00a0521 participants who were at intermediate risk of cardiovascular disease (\n              <jats:styled-content style=\"fixed-case\">CVD<\/jats:styled-content>\n              ) and were randomized to rosuvastatin, candesartan\/hydrochlorothiazide, their combination, or matched placebos. Median follow\u2010up was 5.6\u00a0years. The outcome was a composite of\n              <jats:styled-content style=\"fixed-case\">CVD<\/jats:styled-content>\n              events. Adjusted hazard ratios (\n              <jats:styled-content style=\"fixed-case\">HRs<\/jats:styled-content>\n              ) and 95% confidence intervals (\n              <jats:styled-content style=\"fixed-case\">CIs<\/jats:styled-content>\n              ) were estimated using Cox regression models. Participants with \u22652 healthy lifestyle factors had a lower rate of\n              <jats:styled-content style=\"fixed-case\">CVD<\/jats:styled-content>\n              compared with those with fewer factors (\n              <jats:styled-content style=\"fixed-case\">HR:<\/jats:styled-content>\n              0.85; 95%\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              , 0.73\u20131.00). Rosuvastatin reduced\n              <jats:styled-content style=\"fixed-case\">CVD<\/jats:styled-content>\n              events in participants with \u22652 healthy lifestyle factors (\n              <jats:styled-content style=\"fixed-case\">HR:<\/jats:styled-content>\n              0.74; 95%\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              , 0.62\u20130.90) and in participants with &lt;2 factors (\n              <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n              : 0.79; 95%\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              , 0.61\u20131.01). Consistent results were observed with combination therapy (\u22652 factors:\n              <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n              : 0.74; 95%\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              , 0.57\u20130.97; &lt;2 factors:\n              <jats:styled-content style=\"fixed-case\">HR:<\/jats:styled-content>\n              0.61; 95%\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              , 0.43\u20130.88). Candesartan\/hydrochlorothiazide tends to reduce\n              <jats:styled-content style=\"fixed-case\">CVD<\/jats:styled-content>\n              only in participants with &lt;2 healthy lifestyle factors (\n              <jats:styled-content style=\"fixed-case\">HR:<\/jats:styled-content>\n              0.78; 95%\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              , 0.61\u20131.00).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Healthy lifestyles are associated with lower\n              <jats:styled-content style=\"fixed-case\">CVD<\/jats:styled-content>\n              . Rosuvastatin alone and combined with candesartan\/hydrochlorothiazide is beneficial regardless of healthy lifestyle status; however, the benefit of antihypertensive treatment appears to be limited to patients with less healthy lifestyles.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Clinical Trial Registration<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              <jats:styled-content style=\"fixed-case\">URL<\/jats:styled-content>\n              :\n              <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\">https:\/\/www.clinicaltrials.gov<\/jats:ext-link>\n              . Unique identifier:\n              <jats:styled-content style=\"fixed-case\">NCT<\/jats:styled-content>\n              00239681.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.118.008918","type":"journal-article","created":{"date-parts":[[2018,7,22]],"date-time":"2018-07-22T09:05:10Z","timestamp":1532250310000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of Lipid\u2010Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE\u20103 Trial"],"prefix":"10.1161","volume":"7","author":[{"given":"Gilles R.","family":"Dagenais","sequence":"first","affiliation":[{"name":"Quebec Heart and Lung University Institute Laval University Quebec City Quebec Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyejung","family":"Jung","sequence":"additional","affiliation":[{"name":"Population Health Research Institute Hamilton General Hospital McMaster University Hamilton Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Lonn","sequence":"additional","affiliation":[{"name":"Population Health Research Institute Hamilton General Hospital McMaster University Hamilton Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.","family":"Bogaty","sequence":"additional","affiliation":[{"name":"Quebec Heart and Lung University Institute Laval University Quebec City Quebec Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahshid","family":"Dehghan","sequence":"additional","affiliation":[{"name":"Population Health Research Institute Hamilton General Hospital McMaster University Hamilton Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claes","family":"Held","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Cardiology Uppsala Clinical Research Center Uppsala Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvaro","family":"Avezum","sequence":"additional","affiliation":[{"name":"Dante Pazzanese Institute of Cardiology University Santo Amaro S\u00e3o Paulo Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"Jansky","sequence":"additional","affiliation":[{"name":"University Hospital Motol Prague Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maty\u00e0s","family":"Keltai","sequence":"additional","affiliation":[{"name":"Semmelweis University Budapest Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence A.","family":"Leiter","sequence":"additional","affiliation":[{"name":"Li Ka Shing Knowledge Institute St. Michael's Hospital and Departments of Medicine and Nutritional Sciences University of Toronto Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricio","family":"Lopez\u2010Jaramillo","sequence":"additional","affiliation":[{"name":"Research Department FOSCAL Medical School University of Santander (UDES) Bucaramanga Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William D.","family":"Toff","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences University of Leicester, and NIHR Leicester Biomedical Research Centre Leicester United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackie","family":"Bosch","sequence":"additional","affiliation":[{"name":"Population Health Research Institute Hamilton General Hospital McMaster University Hamilton Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Yusuf","sequence":"additional","affiliation":[{"name":"Population Health Research Institute Hamilton General Hospital McMaster University Hamilton Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200007063430103"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.12.1433"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17018-9"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1440"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60834-3"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1605086"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.621417"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/1010539509347941"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.193961"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03565"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.01.001"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2015.07.001"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1600175"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1600176"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1600177"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa025039"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.118.008918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T11:27:01Z","timestamp":1715599621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.118.008918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,7]]},"references-count":16,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2018,8,7]]}},"alternative-id":["10.1161\/JAHA.118.008918"],"URL":"https:\/\/doi.org\/10.1161\/jaha.118.008918","relation":{},"ISSN":["2047-9980"],"issn-type":[{"type":"electronic","value":"2047-9980"}],"subject":[],"published":{"date-parts":[[2018,8,7]]},"assertion":[{"value":"2018-02-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e008918"}}